GlassScriptPhysician profile
Barbara A Hessel
NPI 1154380095
$2,257.73
in general payments reported to CMS, 2019-2025
29 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $304 · 2021: $472 · 2022: $379 · 2023: $244 · 2024: $435 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $932.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $931.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $238.94 | 2019-2023 | |
| Pfizer INC. | $218.35 | 2021-2024 | |
| Daiichi Sankyo INC. | $197.04 | 2024-2025 | Injectafer |
| Therapeuticsmd, INC. | $194.14 | 2019-2022 | |
| Avion Pharmaceuticals | $152.57 | 2020-2021 | |
| Agile Therapeutics, INC. | $130.96 | 2021-2024 | Twirla |
| Coopersurgical, INC. | $114.85 | 2021-2024 | Paragard T 380a |
| Astellas Pharma US INC | $90.73 | 2023-2025 | Veozah, Myrbetriq |
| Scynexis, INC. | $87.36 | 2022 | |
| Exact Sciences Corporation | $75.78 | 2023-2024 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $70.75 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Evofem Biosciences, INC. | $68.28 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $67.23 | 2021-2025 | |
| Vivus LLC | $61.38 | 2022 | |
| Exeltis, USA INC. | $56.36 | 2019-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $51.98 | 2023-2024 | Myfembree |
| Biogen, INC. | $43.91 | 2024 | Zurzuvae |
| Amag Pharmaceuticals, INC. | $41.54 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.57 | 2025 | |
| Dysis Medical, INC. | $38.38 | 2020-2022 | |
| Currax Pharmaceuticals LLC | $31.06 | 2024 | Contrave |
| Intra-Sana Laboratories | $29.69 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Lilly USA, LLC | $25.94 | 2025 | Zepbound |
| Sanofi Pasteur INC. | $25.19 | 2025 | |
| Ethicon US, LLC | $24.44 | 2022 | |
| Lupin INC. | $23.76 | 2020 | |
| Boston Scientific Corporation | $21.25 | 2023 | Varithena Administration Pack |
| Millicent US INC | $18.64 | 2024 | Femring, Intrarosa |
| Mission Pharmacal Company | $16.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Hessel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.